Skip to content
DraconiticResearch
Search Sources API
186,123 studies31 sourcesUpdated 12 min ago
Peer-reviewedCC BY-NC-NDMicrobiome

Lung microbiota dysbiosis exacerbates influenza virus infection.

4 affiliations
  1. 1College of Life Science and Agriculture Forestry, Qiqihar University, Qiqihar, Heilongjiang, 161006, China.
  2. 2State Key Laboratory for Animal Disease Control and Prevention, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, 150069, China. [email protected].
  3. 3Postdoctoral Research Workstation, Heilongjiang Academy of Agricultural Sciences, Harbin, China. [email protected].
  4. 4State Key Laboratory for Animal Disease Control and Prevention, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, 150069, China. [email protected].

Abstract

Background

Previous studies have shown that microbiota in the respiratory tract play a significant role in shaping host immunity and reducing the risk of respiratory tract infections. Influenza, an acute respiratory infectious disease caused by the influenza virus (IAV), necessitates to have an in-depth understanding of the pathogenic mechanisms of viral infection and to utilize these mechanisms to prevent and control influenza infection.Results

In this study, we established models of different disease severity levels in mice infected with IAV, the relationships between changes in pulmonary microbiota and host interactions during IAV infection were analyzed. We found that these relationships were characterized by the enrichment of opportunistic pathogenic taxonomic groups and were related to disease severity. Multi-omics analysis combined with animal experiments clarified that colonization of Bacillus cereus in the lungs aggravates IAV infection through xanthosine, thereby downregulating the expression of nt5e and reducing the viral phagocytic ability of alveolar macrophages. Importantly, targeted removal of B. cereus by bacteriophages can alleviate IAV infection and the resulting pulmonary lesions.Conclusions

Highlighting provides a novel approach for preventing and controlling the progression of IAV infection by targeting the lung microbiota.In brief

Lung dysbiosis is associated with severe influenza virus (IAV) infection. Bacillus cereus aggravates IAV infection via the xanthosine-nt5e axis in SPF mice, which can be rescued by bacteriophage targeting. These findings highlight the potential of modulating the lung microbiota as a strategy for prevention and controlling IAV infection.

Related

  1. Moderate exercise early after influenza virus infection reduces the Th1 inflammatory response in lungs of mice
    Thomas Lowder, David A. Padgett, Jeffrey A. Woods
    PubMedPeer-reviewedLicence not stated72 citedEpidemiology & public healthOpenAlex
  2. Pulmonary infection caused by Nocardia cyriacigeorgica and influenza A virus coinfection in an immunocompetent patient : A case report
    Zhengfan Yu, Yanmei Zhang, Lijie Qiu +1
    MedicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Human Infection with Avian Influenza A(H7N7) Virus, Taiwan, 2026
    Y.-T. Li, Y.-T. Lin, B.-S. Chen +7
    medRxivPreprintCC BYFull textInfectious diseasemedRxiv
  4. Visualizing Influenza A Virus Infection and Host Processes Using Fluorescence Microscopy.
    Bernhard A Kramer, Janin Schokolowski, Huib H Rabouw
    VirusesPeer-reviewedCC BYFull textEpidemiology & public healthEurope PMCDOAJ
  5. A Monoclonal Antibody Targeting mGluR2 Inhibits H9 Subtype Influenza A Virus Infection In Vitro.
    Pengfei Wang, Chuanchuan Xing, Shengmei Jiao +2
    Veterinary sciencesPeer-reviewedCC BYFull textEpidemiology & public healthEurope PMC
BibTeX
@article{yin2026lung,
  title = {{Lung microbiota dysbiosis exacerbates influenza virus infection.}},
  author = {Hai Chang Yin and Xin Yu Zhang and Song Liu and Xinjie Jiang and Tian Fei Yu and He Zhang and Di Liu and Chang You Xia},
  journal = {Microbiome},
  year = {2026},
  month = sep,
  doi = {10.1186/s40168-026-02450-5},
  url = {https://europepmc.org/article/MED/42850654},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Lung microbiota dysbiosis exacerbates influenza virus infection.
AU  - Hai Chang Yin
AU  - Xin Yu Zhang
AU  - Song Liu
AU  - Xinjie Jiang
AU  - Tian Fei Yu
AU  - He Zhang
AU  - Di Liu
AU  - Chang You Xia
PY  - 2026
DA  - 2026/09/15
JO  - Microbiome
DO  - 10.1186/s40168-026-02450-5
UR  - https://europepmc.org/article/MED/42850654
AB  - Background  Previous studies have shown that microbiota in the respiratory tract play a significant role in shaping host immunity and reducing the risk of respiratory tract infections. Influenza, an acute respiratory infectious disease caused by the influenza virus (IAV), necessitates to have an in-depth understanding of the pathogenic mechanisms of viral infection and to utilize these mechanisms to prevent and control influenza infection.Results  In this study, we established models of different disease severity levels in mice infected with IAV, the relationships between changes in pulmonary microbiota and host interactions during IAV infection were analyzed. We found that these relationships were characterized by the enrichment of opportunistic pathogenic taxonomic groups and were related to disease severity. Multi-omics analysis combined with animal experiments clarified that colonization of Bacillus cereus in the lungs aggravates IAV infection through xanthosine, thereby downregulating the expression of nt5e and reducing the viral phagocytic ability of alveolar macrophages. Importantly, targeted removal of B. cereus by bacteriophages can alleviate IAV infection and the resulting pulmonary lesions.Conclusions  Highlighting provides a novel approach for preventing and controlling the progression of IAV infection by targeting the lung microbiota.In brief  Lung dysbiosis is associated with severe influenza virus (IAV) infection. Bacillus cereus aggravates IAV infection via the xanthosine-nt5e axis in SPF mice, which can be rescued by bacteriophage targeting. These findings highlight the potential of modulating the lung microbiota as a strategy for prevention and controlling IAV infection.
SN  - 2049-2618
ER  -